Cargando…

Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation

OBJECTIVE: The pathogenesis of thrombotic microangiopathy (TMA) in lupus nephritis (LN) remains complicated. This study aimed to detect the deposition of complement lectin pathway (LP) and alternative pathway (AP) components in renal tissues, then evaluate the clinicopathological characteristics and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Binshan, Xing, Guolan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792970/ https://www.ncbi.nlm.nih.gov/pubmed/36582241 http://dx.doi.org/10.3389/fimmu.2022.1081942

Ejemplares similares

Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis
por: Massicotte-Azarniouch, David, et al.
Publicado: (2022)

The spectrum of renal thrombotic microangiopathy in lupus nephritis
por: Song, Di, et al.
Publicado: (2013)

Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
por: Torres, Everardo Arias, et al.
Publicado: (2021)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis
por: Pattanashetti, N., et al.
Publicado: (2017)

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
por: Trojnar, Eszter, et al.
Publicado: (2019)

Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
por: Moscvin, Maria, et al.
Publicado: (2023)

Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19
por: Niederreiter, Janina, et al.
Publicado: (2022)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy
por: Okamura, Hiroshi, et al.
Publicado: (2021)

Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19
por: Niederreiter, Janina, et al.
Publicado: (2023)

Interferon-β1a-Induced Thrombotic Microangiopathy: Possible Implication of the Alternative Pathway of the Complement
por: Taghavi, Maxime, et al.
Publicado: (2022)

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
por: Dobó, József, et al.
Publicado: (2018)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation
por: Kurosawa, Shinichiro, et al.
Publicado: (2014)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

Urinary markers of the alternative and lectin complement pathway are increased in IgA vasculitis nephritis
por: Marro, Julien, et al.
Publicado: (2023)

Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality
por: Defendi, Federica, et al.
Publicado: (2021)

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
por: Rambaldi, Alessandro, et al.
Publicado: (2020)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

The potential role of complements in cocaine-induced thrombotic microangiopathy
por: Dejman, Adriana, et al.
Publicado: (2018)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study
por: Li, Qiu-Yu, et al.
Publicado: (2016)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2021)

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023)

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
por: Bruno, Valentina, et al.
Publicado: (2023)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome
por: Ono, Masafumi, et al.
Publicado: (2018)

Thrombocytopenia Is an Independent Risk Factor for the Prognosis of Thrombotic Microangiopathy in Chinese Patients With Systemic Lupus Erythematosus
por: Yang, Fan, et al.
Publicado: (2021)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System
por: Świerzko, Anna S., et al.
Publicado: (2020)

Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae
por: Belmonte, Beatrice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cvm5f8pajoj8e4gpsv8f7crtsk